HBM Holdings-B (02142) spent nearly 9 million Hong Kong dollars to repurchase shares on June 17th.

HBM HOLDINGS-B (02142) announced a plan to repurchase shares in the market totalling HK$240 million, considering that the current trading price levels undervalue the company's intrinsic value, business prospects, or recent business achievements. On June 17, 2025, the company repurchased shares in the open market, involving nearly HK$9 million, which is a significant repurchase amount for a biotechnology company listed on the Hong Kong Stock Exchange in 2025. The accelerated repurchase progress reflects the company's commitment to enhancing shareholder value and confidence in the company's long-term growth prospects. The company may authorize further repurchase plans based on market conditions, but must comply with the applicable repurchase authorization at that time. The company further stated that, based on the closing price of the company's shares on June 17, 2025, (i) the company's market value divided by the total prepayment and potential milestone payments of approximately USD 5 billion under the new collaborations reached in 2025 is only 0.16; and (ii) the company's market value divided by the total potential milestone payments of approximately USD 10 billion under all group collaborations is only 0.08. The company believes that the current trading price levels of the shares reflect an undervaluation of the company's intrinsic value and business prospects, and reaffirms its strong commitment to maximizing shareholder value.